Abstract
Objective: To review and discuss the mental health needs of children and adolescents in India.
Methods: Recent community-based and clinic-based epidemiological data in child and adolescent psychiatry (CAP) from a tertiary referral center for CAP in India [National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India] are reviewed. Results: The ICD-10 DCR criteria for CAP disorders and Rutter’s penta-axial diagnosis are used in these data. The community prevalence rate for CAP disorders is found to be 12.5% (n = 2064). The most common diagnoses in community are non-organic enuresis (6.2%), specific phobia (2.9%), ADHD (1.6%), stuttering (1.5%) and ODD (0.9%). Only 37.5 per cent of the families perceived that their children had any problem. The profile of CAP disorders among patients presenting to the CAP clinic [n=374 over six months period; age-group 0-16 years; 240 (64%) boys and 134 (36%) girls] differs from that in community: ADHD—16.6% (highest prevalence), autism spectrum disorders—15.5%, depression—12%, dissociative disorders—8.8%, bipolar disorder—4.2% and psychoses—4%. 284 (75%) of children evaluated in the clinic have at least one abnormal psychosocial situation. Physical abuse and the presence of parental psychopathology are significantly associated with psychiatric morbidity. Conclusions: Prevalence rates of CAP morbidity in India are lower than Western figures. With our total population figures, the absolute numbers with psychiatric morbidity would be very large. We discuss the implications for manpower training, practice, awareness building and policy initiatives.Keywords: Child and adolescent mental health, mental health in India, prevalence
Adolescent Psychiatry
Title:Global Child and Adolescent Mental Health Needs: Perspectives from a National Tertiary Referral Center in India
Volume: 3 Issue: 1
Author(s): Tejas S. Golhar and Shoba Srinath
Affiliation:
Keywords: Child and adolescent mental health, mental health in India, prevalence
Abstract: Objective: To review and discuss the mental health needs of children and adolescents in India.
Methods: Recent community-based and clinic-based epidemiological data in child and adolescent psychiatry (CAP) from a tertiary referral center for CAP in India [National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India] are reviewed. Results: The ICD-10 DCR criteria for CAP disorders and Rutter’s penta-axial diagnosis are used in these data. The community prevalence rate for CAP disorders is found to be 12.5% (n = 2064). The most common diagnoses in community are non-organic enuresis (6.2%), specific phobia (2.9%), ADHD (1.6%), stuttering (1.5%) and ODD (0.9%). Only 37.5 per cent of the families perceived that their children had any problem. The profile of CAP disorders among patients presenting to the CAP clinic [n=374 over six months period; age-group 0-16 years; 240 (64%) boys and 134 (36%) girls] differs from that in community: ADHD—16.6% (highest prevalence), autism spectrum disorders—15.5%, depression—12%, dissociative disorders—8.8%, bipolar disorder—4.2% and psychoses—4%. 284 (75%) of children evaluated in the clinic have at least one abnormal psychosocial situation. Physical abuse and the presence of parental psychopathology are significantly associated with psychiatric morbidity. Conclusions: Prevalence rates of CAP morbidity in India are lower than Western figures. With our total population figures, the absolute numbers with psychiatric morbidity would be very large. We discuss the implications for manpower training, practice, awareness building and policy initiatives.Export Options
About this article
Cite this article as:
S. Golhar Tejas and Srinath Shoba, Global Child and Adolescent Mental Health Needs: Perspectives from a National Tertiary Referral Center in India, Adolescent Psychiatry 2013; 3 (1) . https://dx.doi.org/10.2174/2210676611303010014
DOI https://dx.doi.org/10.2174/2210676611303010014 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation
Current Alzheimer Research Research and Development of Nuclear Molecular Imaging in Taiwan
Current Medical Imaging Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Current Alzheimer Research MPP+ Analogs Acting on Mitochondria and Inducing Neuro-Degeneration
Current Medicinal Chemistry Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
Current Medicinal Chemistry Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Disentangling the Role of the Tau Gene Locus in Sporadic Tauopathies
Current Alzheimer Research Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets Pharmacological Prolyl Hydroxylase Domain Inhibition as a Therapeutic Target for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets The Development of Targeted Therapies for Hepatocellular Cancer
Current Pharmaceutical Design Screening of Early and Late Onset Alzheimer’s Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy
Current Alzheimer Research Alzheimer's disease: Targeting the Cholinergic System
Current Neuropharmacology The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics
Current Pharmaceutical Design Translating Genetic Findings into Therapy in Parkinson Disease
Recent Patents on CNS Drug Discovery (Discontinued) Dopamine and the Diseased Brain
CNS & Neurological Disorders - Drug Targets Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy
Current Alzheimer Research Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Zolpidem Therapy for Movement Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Progressive Supranuclear Palsy: Neuropsychopathological, Therapeutical and Bioethical Aspects
Current Alzheimer Research Tau Oligomerization: A Role for Tau Aggregation Intermediates Linked to Neurodegeneration
Current Alzheimer Research